These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8432411)

  • 1. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques.
    Davis SN; Monti L; Piatti PM; Moller N; Ng L; Coppack S; May M; Brown MD; Orskov H; Alberti KG
    Diabetes Res; 1993; 23(1):1-18. PubMed ID: 7924144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slower activation of insulin action in upper body obesity.
    Biolo G; Toigo G; Guarnieri G
    Metabolism; 2001 Jan; 50(1):19-23. PubMed ID: 11172469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid.
    Jacob S; Henriksen EJ; Schiemann AL; Simon I; Clancy DE; Tritschler HJ; Jung WI; Augustin HJ; Dietze GJ
    Arzneimittelforschung; 1995 Aug; 45(8):872-4. PubMed ID: 7575750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial longevity is marked by enhanced insulin sensitivity.
    Wijsman CA; Rozing MP; Streefland TC; le Cessie S; Mooijaart SP; Slagboom PE; Westendorp RG; Pijl H; van Heemst D;
    Aging Cell; 2011 Feb; 10(1):114-21. PubMed ID: 21070591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
    Sindelka G; Skrha J; Hilgertová J; Justová V
    Cas Lek Cesk; 1997 Sep; 136(17):530-2. PubMed ID: 9441013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dyslipidemia and hyperinsulinemia in normoglycemic-obese relatives of patients with non-insulin dependent diabetes mellitus].
    Florez H; Valbuena H; Ryder E; Rincón E; Campos G; Castillo S; González J; Fernández V; Raleigh X; Gómez ME
    Invest Clin; 1995 Sep; 36(3):131-47. PubMed ID: 7548306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria--a Clinical Research Center study.
    Sheu W; Jeng CY; Fuh M; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1156-9. PubMed ID: 8772592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients.
    Potter van Loon BJ; Radder JK; Frölich M; Krans HM; Zwinderman AH; Meinders AE
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S55-61. PubMed ID: 1338387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.